Ca2+-binding protein S100A11: A novel diagnostic marker for breast carcinoma

Oncology Reports

Volumn 23, Issue 5, 2010, Pages 1301-1308

  Liu, Xiang Guo ^a   Wang, Xiao Ping ^a   Li, Wan Feng ^a   Yang, Shuo ^a   Zhou, Xin ^a   Li, Si Jie ^a   Li, Xiang Jun ^a   Hao, Dong Yun ^a,b   Fan, Zhi Min ^a  

^a JILIN UNIVERSITY   (China)

^b JILIN ACADEMY OF AGRICULTURAL SCIENCES   (China)

Author keywords

Breast carcinoma; Differential proteomics; S100A11; Tumor marker

Indexed keywords

CALCIUM BINDING PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

AGE; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MASTECTOMY; PRIORITY JOURNAL; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; AMINO ACID SEQUENCE; BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHI-SQUARE DISTRIBUTION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEOMICS; S100 PROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 77950791458     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000764     Document Type: Article

References (39)

1. Esteva FJ and Hortobagyi GN: Prognostic molecular markers in early breast cancer. Breast Cancer Res 6: 109-118, 2004.
2. Hondermarck H: Breast cancer: when proteomics challenges biological complexity. Mol Cell Proteomics 2: 281-291, 2003.
3. Eifel P, Axelson JA, Costa J, Crowley J, Curran WJ Jr, Deshler A, Fulton S, Hendricks CB, Kemeny M, Kornblith AB, Louis TA, Markman M, Mayer R and Roter D: National institutes of health consensus development conference statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst 93: 979-989, 2001.
4. Marenholz I, Heizmann CW and Fritz G: S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun 322: 1111-1122, 2004.
5. Donato R: S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33: 637-668, 2001.
6. Heizmann CW, Fritz G and Schafer BW: S100 proteins: structure, functions and pathology. Front Biosci 7: d1356-d1368, 2002.
7. Harpio R and Einarsson R: S100 proteins as cancer biomarkers with focus on S100b in malignant melanoma. Clin Biochem 37: 512-518, 2004.
8. Salama I, Malone PS, Mihaimeed F and Jones JL: A review of the S100 proteins in cancer. Eur J Surg Oncol 34: 357-364, 2008.
9. Liu D, Rudland PS, Sibson DR, Platt-Higgins A and Barraclough R: Expression of calcium-binding protein S100A2 in breast lesions. Br J Cancer 83: 1473-1479, 2000.
10. Mazzucchelli L: Protein S100A4: too long overlooked by pathologists? Am J Pathol 160: 7-13, 2002.
11. Tanaka M, Adzuma K, Iwami M, Yoshimoto K, Monden Y and Itakura M: Human calgizzarin; one colorectal cancer-related gene selected by a large scale random cDNA sequencing and Northern blot analysis. Cancer Lett 89: 195-200, 1995.
12. 2+- and TGFbeta-induced inhibition of growth of normal human keratinocytes. Proc Natl Acad Sci USA 102: 13921-13926, 2005.
13. Sakaguchi M, Miyazaki M, Takaishi M, Sakaguchi Y, Makino E, Kataoka N, Yamada H, Namba M and Huh NH: S100C/A11 is a key mediator of Ca(2+)-induced growth inhibition of human epidermal keratinocytes. J Cell Biol 163: 825-835, 2003.
14. Sakaguchi M, Miyazaki M, Sonegawa H, Kashiwagi M, Ohba M, Kuroki T, Namba M and Huh NH: PKCalpha mediates TGFbeta-induced growth inhibition of human keratinocytes via phosphorylation of S100C/A11. J Cell Biol 164: 979-984, 2004.
15. Oue N, Hamai Y, Mitani Y, Matsumura S, Oshimo Y, Aung PP, Kuraoka K, Nakayama H and Yasui W: Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis and carcinogenesis by serial analysis of gene expression. Cancer Res 64: 2397-2405, 2004.
16. Rehman I, Azzouzi AR, Cross SS, Deloulme JC, Catto JW, Wylde N, Larre S, Champigneuille J and Hamdy FC: Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions. Hum Pathol 35: 1385-1391, 2004.
17. Ji J, Zhao L, Wang X, Zhou C, Ding F, Su L, Zhang C, Mao X, Wu M and Liu Z: Differential expression of S100 gene family in human esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 130: 480-486, 2004. (Pubitemid 39119292)
18. Nakamura T, Furukawa Y, Nakagawa H, Tsunoda T, Ohigashi H, Murata K, Ishikawa O, Ohgaki K, Kashimura N, Miyamoto M, Hirano S, Kondo S, Katoh H, Nakamura Y and Katagiri T: Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection. Oncogene 23: 2385-2400, 2004.
19. Ohuchida K, Mizumoto K, Ohhashi S, Yamaguchi H, Konomi H, Nagai E, Yamaguchi K, Tsuneyoshi M and Tanaka M: S100A11, a putative tumor suppressor gene, is overexpressed in pancreatic carcinogenesis. Clin Cancer Res 12: 5417-5422, 2006.
20. Kanamori T, Takakura K, Mandai M, Kariya M, Fukuhara K, Sakaguchi M, Huh NH, Saito K, Sakurai T, Fujita J and Fujii S: Increased expression of calcium-binding protein S100 in human uterine smooth muscle tumours. Mol Hum Reprod 10: 735-742, 2004.
21. Wang G, Wang X, Wang S, Song H, Sun H, Yuan W, Cao B, Bai J and Fu S: Colorectal cancer progression correlates with up-regulation of S100A11 expression in tumor tissues. Int J Colorectal Dis 23: 675-682, 2008.
22. Kondo A, Sakaguchi M, Makino E, Namba M, Okada S and Huh NH: Localization of S100C immunoreactivity in various human tissues. Acta Med Okayama 56: 31-34, 2002.
23. Cross SS, Hamdy FC, Deloulme JC and Rehman I: Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology 46: 256-269, 2005.
24. Seidal T, Balaton AJ and Battifora H: Interpretation and quantification of immunostains. Am J Surg Pathol 25: 1204-1207, 2001.
25. Walker RA: Quantification of immunohistochemistry - issues concerning methods, utility and semi-quantitative assessment I. Histopathology 49: 406-410, 2006.
26. Srinivas PR, Srivastava S, Hanash S and Wright GL Jr: Proteomics in early detection of cancer. Clin Chem 47: 1901-1911, 2001.
27. Wulfkuhle JD, Liotta LA and Petricoin EF: Proteomic applications for the early detection of cancer. Nat Rev Cancer 3: 267-275, 2003.
28. Polyak K: On the birth of breast cancer. Biochim Biophys Acta 1552: 1-13, 2001.
29. Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L, Akslen LA, Ragaz J, Gown AM, Gilks CB, van de Rijn M and Perou CM: Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10: 5367-5374, 2004.
30. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO and Botstein D: Molecular portraits of human breast tumours. Nature 406: 747-752, 2000.
31. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P and Borresen-Dale AL: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98: 10869-10874, 2001.
32. Sun B, Zhang S, Zhang D, Li Y, Zhao X, Luo Y and Guo Y: Identification of metastasis-related proteins and their clinical relevance to triple-negative human breast cancer. Clin Cancer Res 14: 7050-7059, 2008.
33. Somiari RI, Sullivan A, Russell S, Somiari S, Hu H, Jordan R, George A, Katenhusen R, Buchowiecka A, Arciero C, Brzeski H, Hooke J and Shriver C: High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast. Proteomics 3: 1863-1873, 2003.
34. Goncalves A, Charafe-Jauffret E, Bertucci F, Audebert S, Toiron Y, Esterni B, Monville F, Tarpin C, Jacquemier J, Houvenaeghel G, Chabannon C, Extra JM, Viens P, Borg JP and Birnbaum D: Protein profiling of human breast tumor cells identifies novel biomarkers associated with molecular subtypes. Mol Cell Proteomics 7: 1420-1433, 2008.
35. Sakaguchi M, Sonegawa H, Murata H, Kitazoe M, Futami J, Kataoka K, Yamada H and Huh NH: S100A11, an dual mediator for growth regulation of human keratinocytes. Mol Biol Cell 19: 78-85, 2008.
36. Hopkinson A, McIntosh RS, Layfield R, Keyte J, Dua HS and Tighe PJ: Optimised two-dimensional eletrophoresis procedures for the protein characterisation of structural tissues. Proteomics 5: 1967-1979, 2005.
37. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
38. Xi J, Wang X, Li S, Zhou X, Yue L, Fan J and Hao D: Polyethylene glycol fractionation improved detection of lowabundant proteins by two-dimensional electrophoresis analysis of plant proteome. Phytochemistry 67: 2341-2348, 2006.
39. Yan JX, Wait R, Berkelman T, Harry RA, Westbrook JA, Wheeler CH and Dunn MJ: A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry. Electrophoresis 21: 3666-3672, 2000.